Trending Sources

San Diego Innovation Economy Extended Gains in 2015: Connect Report

Xconomy

That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship.

Q2 VC Funding Soars in San Diego (After Revisions), and Top 10 Deals

Xconomy

But the San Diego data was off. million in 19 companies in San Diego. million invested in 23 San Diego companies.

Santa Barbara, San Diego Tops On Per-Capita Venture Capital

socalTECH

San Diego-Carlsbad-San Marcos was number 7, with $36.6M in deals and 3.3 San Jose-Sunnyvale-Santa Clara; 2. READ MORE>>.

Synthetic Genomics Creates Host Organism Optimized for Bio Industry

Xconomy

According to the company, the findings reported today set the stage for commercialization of Vmax cells for molecular cloning and protein expression.

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy

and San Diego’s Avalon Ventures. The first-in-human trials of AVB-620 began last year at UC San Diego’s Moores Cancer Center.

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning

Xconomy

Nervana, which now has 48 employees, plans to remain in San Diego and operate under its own brand name.

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent

Xconomy

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

IBM Watson Health Launches Imaging Effort for Cancer, Other Diseases

Xconomy

That means doctors should be able to use Watson to read and digest health records, lab results, radiology reports, and relevant medical literature.

IBM 36

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA

Xconomy

Heather and Jessica Tomko will tell you that they’re nothing alike. They’ve got different interests, different tastes in movies, television, and music.

San Diego, Irvine Tops For Engineering Job Demand, Says Report

socalTECH

Two, Southern California markets-- San Diego and Irvine --are among the top ares for engineering job demand, according to a report today.

Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing

Xconomy

Spinal muscular atrophy affects over 25,000 people in the U.S. and stops many of them from ever being able to walk.

Study 28

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —South San Francisco-based Second Genome hired a new CEO and president. The week started on a reflective note. And perhaps most important, there was the U.S. Or not.

News 28

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. Talk about sacrifice.

Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug

Xconomy

Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101.

Study 15

MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff

Xconomy

months in previously untreated elderly patients who received the drug.

Study 12

Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

Xconomy

—Bruce Bigelow profiled Dauntless Pharmaceuticals , a stealthy biotech company creator in San Diego forming single-drug startups. —San Francisco gene therapy startup Audentes Pharmaceuticals (NASDAQ: BOLD ) raised $75 million in an IPO , selling 5 million shares at $15 apiece, right in its projected range.

What Startups Can Do About Cyber Attacks

Xconomy

These statistics belie the common notion that cybercriminals attack only big businesses. Good Cybersecurity Program Matters. Understand the Risks.

Pharma’s Productivity Problem: Finding More Blockbuster Drugs

Xconomy

recent Silicon Valley Bank report noted that large corporations have dramatically increased pre-clinical acquisitions in the last three years under the pressure of limited supply and competition from IPOs.  The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

Xconomy

center led by the Scripps Research Institute in San Diego will work on ways for those individuals to participate.

PMI 18

Overcoming the Cybersecurity Skills Gap

Xconomy

For example, does the team spend too much time pulling data and formatting reports, or managing IT tickets? Have a plan that expects to change.

Two San Diego Sites Rank Tops In Rising Social Networking Interest

socalTECH

Image courtesy Bigstock. READ MORE>>. social networking analysis pinterest experian skillwho stocktwits ranking

Study 13

Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More

Xconomy

STAT was among the outlets to report that Gilead has also quietly raised prices on older HIV drugs, ostensibly to drive prescriptions toward newer alternatives. San Francisco’s Medivation (NASDAQ: MDVN ), co-owner of prostate cancer drug enzalutamide (Xtandi), remains biotech’s hottest target.

News 15

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Xconomy

The wait continues. Will next week be the week a decision finally comes? Next month? Later today? Until then everyone sits, waits, and speculates.

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J. Bigelow contributed to this report.

Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More

Xconomy

— Bezinga first reported this week that Ron Farkas, head of the FDA team that reviewed the Duchenne muscular dystrophy drug eteplirsen from Sarepta Therapeutics (NASDAQ: SRPT ), recently left the agency. Alex Lash contributed to this report. Let’s get right to it. The drug is currently under FDA review. Shaw Research.

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

The filing held some surprises , however, as Xconomy reported: plans to convert about $200 million in debt—a massive amount for a privately held biotech—into shares at the IPO, with some of those shares holding special privileges for their owners. —Ben Fidler contributed to this report. right now.

News 15

Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More

Xconomy

CARB-X will also run four accelerators—in San Francisco, Cambridge, MA, and two in the U.K. —Ben Fidler contributed to this report.

Study 21

Websense, After Move From San Diego, In Acquisition Talks

socalTECH

Former San Diego-based security software developer Websense > --one of a number of companies acquired by private equity investor Vista Equity Partners and moved out of San Diego--is now in talks to be acquired by Raytheon , according to a report. Websense was acquired by Vista Equity Partners in 2013. READ MORE>>.

How Cyber Visibility Protects Against the Abnormal & the Immoral

Xconomy

For many Bostonians, the “privacy incident” recently disclosed by Massachusetts General Hospital (MGH)—which reportedly involved the personal information of 4,300 dental patients stored by a software vendor—hit close to home in many ways, as most of us have at one time or another been to MGH for ourselves or a loved one.

The XX Factor: Fixing Biotech’s Gender Imbalance in the C-Suite

Xconomy

Since that event in January, which gained significant media attention, further reports have brought attention to the severe biotech gender gap. recent report by the American Association of University Women found that 63 percent of all U.S. Other reports put the percentage much higher. Root of the Problem Runs Deep.

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

Xconomy

—The Associated Press reported that surgeon Paolo Macchiarini faces involuntary manslaughter charges in Sweden related to two patients who died after surgeries he conducted to implant artificial tracheas to replace their damaged windpipes. Savara now aims to pull together a funding round to support a future IPO, David Holley reports.

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. —At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves.

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

San Carlos, CA-based BioCardia will also go public via a reverse merger , four months after dropping plans for an IPO. Morgan party.

San Diego's Mapp Bio Behind Experimental Ebola Drug

socalTECH

A San Diego-based biopharmaceuticals startup, Mapp Biopharmaceuticals , is the source of the experimental Ebola treatment that has been given to the two Americans who are being treated for the dreaded disease, according to CNN. Mapp Biopharmaceutical is backed by LeafBio, Defyrus Inc., the U.S. READ MORE>>.

Texas Looks To Steal Away Another San Diego Company, Omnitracs

socalTECH

According to reports, Omnitracs is in the midst of negotations to move its operations out of San Diego, and to Austin, following the recent sale of Omnitracs by Qualcomm to private equity firm Vista Equity Partners. texas diego omnitracs jobs employment READ MORE>>.

Ostendo Raising Funds to Advance Virtual Reality Display Technology

Xconomy

Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter. Razi, Bussel, and Dull are also on the board of Ingenu, the San Diego wireless technology company known previously as On-Ramp Wireless.

Balancing Risks and Opportunities: The Board’s Perspective

Xconomy

Once risk professionals have a seat at the table, the onus is on them to report risk data to the board as effectively as possible. It’s also important to set a context for the issues that are reported. People start a business for many reasons. Some do it out of sheer passion, while others do it to create wealth and economic growth.

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. —Buzzfeed ran a lengthy report Wednesday on the sexual harassment charges against University of Washington vaccine researcher Michael Katze.

New Report Details Technology Job Concentration In Region

socalTECH

The highest ranked was San Diego-Carlsbad-San Marcos , with 11.1 percent of jobs in technology, ranked at 20. READ MORE>>.